Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Paty

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology|December 29, 2005
The natural history of primary progressive MS in British Columbia, CanadaHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|January 26, 2006
Disability progression in multiple sclerosis is slower than previously reportedHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled studyHillel Panitch, Aaron Miller, Donald Paty, et al.
Advances in Neurology|January 13, 2006
The use of MRI as an outcome measure in clinical trialsDavid K B Li, Mary Jane Li, Anthony Traboulsee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology|December 29, 2005
The natural history of primary progressive MS in British Columbia, CanadaHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|January 26, 2006
Disability progression in multiple sclerosis is slower than previously reportedHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled studyHillel Panitch, Aaron Miller, Donald Paty, et al.
Advances in Neurology|January 13, 2006
The use of MRI as an outcome measure in clinical trialsDavid K B Li, Mary Jane Li, Anthony Traboulsee, et al.
Pageof 1